Anti-CD20/CD3 T cell–dependent bispecific antibody for the treatment of B cell malignancies
2015; American Association for the Advancement of Science; Volume: 7; Issue: 287 Linguagem: Inglês
10.1126/scitranslmed.aaa4802
ISSN1946-6242
AutoresLiping Sun, Diego Ellerman, Mary Mathieu, Maria Hristopoulos, Xiaocheng Chen, Yijin Li, Xiao‐Jie Yan, Robyn Clark, Arthur E. Reyes, Eric Stefanich, Elaine Mai, Judy Young, Clarissa Johnson, Mahrukh Huseni, Xinhua Wang, Yvonne Chen, Peiyin Wang, Hong Wang, Noël Dybdal, Yu‐Waye Chu, Nicholas Chiorazzi, Justin M. Scheer, Teemu T. Junttila, Klára Tótpál, Mark S. Dennis, Allen Ebens,
Tópico(s)Lymphoma Diagnosis and Treatment
ResumoAnti-CD20/CD3 T cell–dependent bispecific antibodies may be useful for the treatment of B cell malignancies.
Referência(s)